AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05645003 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham rTMS Protocol
Description: It was planned to apply a to the dorsolateral prefrontal cortex daily for 15 sessions. Along with the daily rTMS session, patients will continue to use the drugs in the medical treatment (pregabalin, gabapentin, carbamazepine) at the same effective dose. No dose changes will be made during rTMS sessions.
Study NCT03258658 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Autologous Engineered Urethral Construct
Description: urethral construct
Study NCT04809103 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cis-diamminedichloroplatinum
Description: Cisplatin delivered bronchoscopically at the time of diagnosis of NSCLC
Study NCT05641142 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: monitoring the use of anticoagulant and/or antiplatelet therapy in patients with osler rendering disease
Description: Monitoring:~* hemoglobin and ferritin levels~* transfusion or intravenous iron~* hospitalization for bleeding or thrombose~* digestive bleeding and/or another haemorrhagic accident~* severity of epistaxis~* quality of life
Study NCT04889976 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Double Active: Active portable transcranial stimulation (ptES) and active internet-based behavioral therapy (iBT)
Description: ptES is delivered by the Flow device (Flow Neuroscience, Malmö, Sweden), consisting of a one-size-fits-all, transcranial direct current stimulation (tDCS) headset with circular electrodes (area = 22.9cm2). The anode is positioned over the left prefrontal cortex, and the cathode over the right prefrontal cortex. Current strength is set at 2mA (current density = 0.087mA/cm2) for 30 minutes, daily for 5 continuous days (with a 2-day pause) for the first 3 weeks, with twice-weekly sessions for the following 3 weeks (total of 21 sessions in 6 weeks). Active iBT consists of a smartphone app with an electronic therapist-avatar. The iBT sessions are delivered concomitantly to the tDCS sessions (the tDCS device connects via bluetooth to the participant's smartphone app).
Study NCT04889976 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: ptES-only: Active portable transcranial stimulation (ptES) and sham internet-based behavioral therapy (iBT)
Description: ptES is delivered by the Flow device (Flow Neuroscience, Malmö, Sweden), consisting of a one-size-fits-all, transcranial direct current stimulation (tDCS) headset with circular electrodes (area = 22.9cm2). The anode is positioned over the left prefrontal cortex, and the cathode over the right prefrontal cortex. Current strength is set at 2mA (current density = 0.087mA/cm2) for 30 minutes, daily for 5 continuous days (with a 2-day pause) for the first 3 weeks, with twice-weekly sessions for the following 3 weeks (total of 21 sessions in 6 weeks). The sham iBT sessions are delivered concomitantly to the active ptES sessions (the ptES device connects via bluetooth to the participant's smartphone app).
Study NCT04889976 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Double-sham: Sham portable transcranial stimulation (ptES) and sham internet-based behavioral therapy (iBT)
Description: Sham ptES for this trial is delivered by the Flow device (Flow Neuroscience, Malmö, Sweden), consisting of a one-size-fits-all transcranial direct current stimulation (tDCS) headset, with circular electrodes (area = 22.9cm2). The anode is positioned over the left prefrontal cortex, and the cathode over the right prefrontal cortex. The sham protocol consists of a fade-in and fade-out phases of 1mA for 45 seconds, followed by a silent period in between for the remaining 28 1/2 minutes. The sham iBT sessions are delivered concomitantly to the sham ptES sessions (the ptES device connects via bluetooth to the participant's smartphone app).
Study NCT04341376 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Enhanced First Connections
Description: Enhanced First Connections is a short-term home visiting program that includes prenatal identification and engagement of women with an adversity or trauma history, and infant and early childhood mental health consultation.
Study NCT06202092 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Phonophoresis
Description: Ultrasound using honey as a media over the knee joint
Study NCT06202092 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Ultrasound
Description: ultrasound using gel as a media over the knee joint
Study NCT06202092 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: conventional physiotherapy
Description: TENS, Strengthening, and stretching exercises
Study NCT06202092 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: conventional physiotherapy
Description: TENS, Strengthening, and stretching exercises
Study NCT06453642 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: GPX® Embolic Device
Description: Treatment includes distal embolization in the peripheral vasculature of vascular tumors, renal embolization, and portal vein branches
Study NCT05481541 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: written education
Description: Other names:~Written/E-Mobile training The study was conducted as a three-group randomized controlled trial to examine the effect of written/mobile education on the quality of life and sleep of patients undergoing transurethral resection of the prostate. Written education was applied to the first group and mobile education was applied to the second group. Group 3 formed the control group.
Study NCT05481541 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: written education
Description: Other names:~Written/E-Mobile training The study was conducted as a three-group randomized controlled trial to examine the effect of written/mobile education on the quality of life and sleep of patients undergoing transurethral resection of the prostate. Written education was applied to the first group and mobile education was applied to the second group. Group 3 formed the control group.
Study NCT04836325 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: transcranial static magnetic field stimulation (tSMS)
Description: The intervention group will receive a treatment of tSMS in the primary motor cortex.
Study NCT04836325 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Sham transcranial static magnetic field stimulation
Description: The placebo group will receive a dummy treatment
Study NCT04650880 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Vitamin D
Description: Vitamin D supplementation
Study NCT04650880 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo tablets with the same external appearance
Study NCT05202158 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Addition of gentamicin to irrigation fluid during RIRS
Description: During the RIRS, the access sheath is placed first for security. Then, the stone in the kidney is detected with flexible URS and fragmented with a holmium laser. In this group of patients, 80 mg of gentamicin will be added to 3 liters of irrigation fluid while the stone is being fragmented.
Study NCT05202158 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Only irrigation fluid during RIRS
Description: During the RIRS, the access sheath is placed first for security. Then, the stone in the kidney is detected with flexible URS and fragmented with a holmium laser. In this group of patients, only irrigation fluid will be used while the stone is fragmented.
Study NCT05569460 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: No intervention
Study NCT06326307 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Tell Show and Do Guidance
Description: In this technique, the dentist tells explains the procedure using the Tell show and do method.
Study NCT06326307 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Puppet Guidance
Description: In this technique, the dentist using the puppet to explains the procedure.
Study NCT05463094 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Test Glucophage® XR
Description: Participants will receive single oral dose of Test GXR RM tablet under fasted or fed conditions.
Study NCT05463094 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Reference Glucophage® XR
Description: Participants will receive single oral dose of Reference GXR RM tablet under fasted or fed conditions.
Study NCT05084404 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Experimental: 4 mg/day of WY-8678 (guanabenz acetate)
Description: Patients with nonalcoholic fatty liver disease are administered 4 mg/day of WY-8678 (guanabenz acetate) twice daily for 16 weeks
Study NCT05084404 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Experimental: 8 mg/day of WY-8678 (guanabenz acetate)
Description: Patients with nonalcoholic fatty liver disease are administered 8 mg/day of WY-8678 (guanabenz acetate) twice daily for 16 weeks
Study NCT04988594 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Lactobacillus acidophilus 207, Bifidobacterium lactis B420/205
Description: Cultures containing 3.7 × 10 \^ 9 CFU/mg
Study NCT04988594 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Lactobacillus bulgaricus and Streptococcus thermophillus
Description: Cultures containing 3.7 × 10 \^ 6 CFU/mg
Study NCT04988594 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: No culture
Description: No probiotic cultures
Study NCT06509568 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemoradiotherapy followed by immunotherapy
Description: Patients in the nCRIT group will receive neoadjuvant concurrent chemoradiotherapy: radiation therapy will be administered using IMRT or VMAT with involved-field irradiation at a dose of PTV 41.4 Gy/23 fractions/31 days. Chemotherapy will consist of weekly administration of paclitaxel (albumin-bound) 50 mg/m² and carboplatin (AUC 2) for five weeks, given on the days of radiotherapy. Patients who do not progress on CT and meet immunotherapy criteria will receive fixed-dose toripalimab (200 mg IV) on days 8 and 29 after chemoradiotherapy, followed by minimally invasive esophagectomy four weeks after completing immunotherapy.
Study NCT06509568 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Neoadjuvant chemoimmunotherapy
Description: Patients in the nCIT group will receive two cycles of TC chemotherapy combined with immunotherapy, specifically paclitaxel (albumin-bound) 100 mg/m² on days 1, 8, 15 or 260mg/m² d1, carboplatin (AUC=5) on days 1, and toripalimab (200 mg) on days 1. Minimally invasive esophagectomy will be performed 4-6 weeks after completing chemotherapy, and adjuvant immunotherapy is recommended for one year after surgery.
Study NCT05131113 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physical exercise
Description: Physical exercise
Study NCT06124638 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Panbio™ COVID-19/Flu A&B Panel
Description: The Panbio™ COVID-19/Flu A\&B Rapid Panel Self-Test device is a visual lateral flow assay, for rapid immunochromatographic qualitative detection of COVID-19 antigen, Influenza A antigen and Influenza B antigen in self-collected mid-turbinate nasal swabs. The test is designed to be used by lay users.
Study NCT01668264 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Echocardiograph
Study NCT01668264 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging (MRI)
Study NCT05672836 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Enavogliflozin
Description: 0.3 mg 1 tablet once daily
Study NCT05672836 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Standard-of-Care
Description: Standard-of-Care medical therapy plus Enavogliflozin matching placebo
Study NCT04455841 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: INCB000928
Description: INCB000928 will be administered at protocol defined dose.
Study NCT05001633 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: modified media content paradigm
Description: media content
Study NCT05001633 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: control
Description: media content experience
Study NCT04455841 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ruxolitinib
Description: Ruxolitinib will be administered at protocol defined dose.
Study NCT04364126 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Home blood pressure apparatus
Description: Target \<125/80 mmHg
Study NCT04364126 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Clinic blood pressure
Description: Target \<130/80 mmHg
Study NCT05885971 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Administration of the SCOFF-F and EDE-Q questionnaires
Description: The participants will answer to the SCOFF-F and EDE-Q questionnaires as well as socio-demographic questions
Study NCT05265728 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Natalizumab
Description: Administered as specified in the treatment arm
Study NCT05502536 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Traditional rehabilitation programs with Individualized fairytales class
Description: In addition to traditional rehabilitation programs, 30 minutes per week for 12 sessions of individualized fairytales classes by a child and educational teacher for three months, to preschool children with Attention Deficit Hyperactivity Disorder and developmental delays in regular traditional rehabilitation programs
Study NCT05236387 — intervention group
Intervention type: DRUG
Intervention: 99m Tc-TM
Description: Each patient will receive a single injection (0.1 ml) of 99mTc-TM (50 mcg) at the upper outer skin of the breast using an intradermal technique confirmed by the presence of a skin wheal.
Study NCT05661097 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Suture mode
Description: Patients in the small hernia ring group received continuous suture with barbed wire according to simple random method Closure mode, intermittent full layer suture by hernia hook needle.Patients in the large hernia ring group received continuous suture with barbed wire according to simple random method Closure mode, intermittent full layer suture with hernia hook needle, continuous suture with barbed wire+hernia Intermittent full layer crochet suture.
Study NCT05661097 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Suture mode
Description: Patients in the small hernia ring group received continuous suture with barbed wire according to simple random method Closure mode, intermittent full layer suture by hernia hook needle.Patients in the large hernia ring group received continuous suture with barbed wire according to simple random method Closure mode, intermittent full layer suture with hernia hook needle, continuous suture with barbed wire+hernia Intermittent full layer crochet suture.
Study NCT05719142 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Picture exposure
Description: Participants are shown pictures for 15 minutes; 50 images in total, each shown for 6 seconds, and 3 times in total.
Study NCT05175118 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Minimal invasive surgical fixation of distal radius Fractures
Description: Fixation of distal radius Fractures by minimal invasive technique
Study NCT06433362 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CMOEP
Description: Drug: Mitoxantrone hydrochloride liposome Mitoxantrone hydrochloride liposome (18 mg/m\^2) on day 1, every 3 weeks; Drug: Cyclophosphamide Cyclophosphamide(750 mg/m\^2) on day 1,every 3 weeks; Drug: Vincristine Vincristine (1.4mg/ m2，Max dose 2mg) will be administered by an intravenous injection on day 1(Or at the discretion of the investigator, use other vinblastine drugs with the same mechanism, such as vindesine 3 mg/m2, the maximum dose of 4mg),every 3 weeks; Drug: Etoposide Etoposide (60 mg/ m2) will be administered by an intravenous infusion on day 1-3,every 3 weeks;
Study NCT05632991 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: ultrasound guided external oblique intercostal plane block
Description: ultrasound guided external oblique intercostal plane block 20 ml local anesthetic each side
Study NCT05632991 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Subcostal Transversus Abdominis Plan Block Group
Description: ultrasound guided Subcostal Transversus Abdominis Plan Block Group 20 ml local anesthetic each side
Study NCT06096675 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: • Cardiac Rehabilitation
Description: Intervention group will have baseline 6-minute walk test and cardiopulmonary exercise test (CPET) testing followed by supervised cardiac rehabilitation program including planned 3 one hour sessions a week for a total of 12 weeks (planned 36 sessions). A post intervention 6-minute walk test and CPET test will be performed within 2 weeks of completion of the 12 week program.
Study NCT04864860 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: brown seaweed (ecklonia cava)
Description: The intervention product used in this study is a dietary supplement called Seanol that contain 13% pholoratannic polyphenol per capsule as stated by the manufacture company (Seanol inside, 4215 95th St SW Lakewood, WA 98499 USA). Other ingredients are dextrin, magnesium stearate and silica (in neglected percentage). The intervention supplement is encapsulated in vegetable cellulose that contains 500 Ecklonia cava extract (Seanol). The placebo will be dextrin (BETA CYCLODEXTRIN, NF) ordered from a pharmaceutical company MEDISCA (https://www.medisca.co.uk/). Dextrin was selected to account for the similar complex carbohydrate content of the intervention supplement. Placebo will be encapsulated in vegetable cellulose capsules that is identical in size and coulure to the intervention capsules. The empty capsules will be ordered from MEDISCA and will be encapsulated in by SPIMACO ADDWAIEH (SFDA registered pharmaceutical company) (http://www.spimaco.com.sa/).
Study NCT06214390 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Single strategy
Description: In the single strategy, RRT weaning will be achieved when urine output exceeds 500ml/24h without diuretics or 2000ml/24h with diuretics use
Study NCT06214390 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Combined strategy
Description: In the combined strategy, when urine output exceeds 500ml/day with or without diuretic use, RRT will be stopped during 48h to assess urinary indices (urinary creatinine and urea). Soon as urinary indices are higher than thresholds values (urinary creatinine > 5.2mmol/day \[5\] and 3) urinary urea > 1.35mmol/kg/day (using the patient's body weight at ICU admission) \[6\], RRT will be weaned. If they are lower, a RRT session will be perform after which the weaning process will be resume.
Study NCT04864860 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: brown seaweed (ecklonia cava)
Description: The intervention product used in this study is a dietary supplement called Seanol that contain 13% pholoratannic polyphenol per capsule as stated by the manufacture company (Seanol inside, 4215 95th St SW Lakewood, WA 98499 USA). Other ingredients are dextrin, magnesium stearate and silica (in neglected percentage). The intervention supplement is encapsulated in vegetable cellulose that contains 500 Ecklonia cava extract (Seanol). The placebo will be dextrin (BETA CYCLODEXTRIN, NF) ordered from a pharmaceutical company MEDISCA (https://www.medisca.co.uk/). Dextrin was selected to account for the similar complex carbohydrate content of the intervention supplement. Placebo will be encapsulated in vegetable cellulose capsules that is identical in size and coulure to the intervention capsules. The empty capsules will be ordered from MEDISCA and will be encapsulated in by SPIMACO ADDWAIEH (SFDA registered pharmaceutical company) (http://www.spimaco.com.sa/).
Study NCT05167383 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: VRH (Virtual Reality Hypnosis)
Description: Hypnosis is delivered as a standardized therapeutic intervention through virtual reality, using a digital sedation software (AQUA ®, Onfomfort SA).
Study NCT05167383 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard care
Description: The standard treatment (ST) for labor pain as used in our hospital contains massage, aquatherapy and postural exercises. This is always available for any woman in labor.
Study NCT05167383 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Standard care
Description: The standard treatment (ST) for labor pain as used in our hospital contains massage, aquatherapy and postural exercises. This is always available for any woman in labor.
Study NCT06171308 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Traditional Chinese moxibustion apparatus
Description: The study group was treated with traditional Chinese moxibustion and western medicine. The control group was treated with blank moxibustion and western medicine.~1. The study group: Using the moxibustion, select specific 3 groups of acupoints. Select a group of acupuncture points every day, in the moxibustion treatment for 20 minutes, 4 weeks for a course of treatment.~2. The control group: Using the moxibustion with blank patch, select specific 3 groups of acupoints. Select a group of acupuncture points every day, in the moxibustion treatment for 20 minutes, 4 weeks for a course of treatment.~3. The treatment period is 4 weeks, which is a course of treatment, and the observation period is 8 weeks.